Objective/Hypothesis: The immortalizing enzyme telomerase has been linked t
o carcinogenesis and is being targeted as a novel molecular marker. This st
udy investigated telomerase expression in patients with laryngeal squamous
cell carcinoma and correlated telomerase activity with conventional prognos
tic parameters. Study Design: A consecutive series of patients with larynge
al squamous cell carcinoma undergoing surgical salvage for persistent or pr
ogressive disease after failed radiation therapy. Methods: Twenty patient s
amples of laryngeal squamous cell carcinoma and 20 adjacent histologically
normal mucosal samples were assayed using the telomeric repeat amplificatio
n protocol (TRAP) method for detection of telomerase activity. The leukemic
cell line, K562, acted as a positive control and the human fibroblast line
, Hs21Fs, as a negative control. A sample was classified as telomerase posi
tive when an RNase-sensitive hexameric repeat ladder was observed. Absence
of laddering was considered a negative result. Results: Seventeen of 20 (85
%) tumor samples and 4 of 20 (20%) adjacent histologically normal samples w
ere telomerase positive. No statistically significant difference was observ
ed when densitometric readings were compared by T category, tumor grade, or
site (by ANOVA). Conclusions: Although telomerase activity is present in l
aryngeal cancer, levels of activation do not correlate with conventional pa
rameters used for prognostication, Our study indicates that the marker may
be a useful adjunctive method in the diagnosis of malignancy after radiatio
n failure.